Odyssey Health Extends Maturity Dates on Promissory and Convertible NotesOn February 13, 2025, Odyssey Health, Inc. (OTCMKTS:ODYY) announced in an 8-K filing the extension of maturity dates on two important financial agreements. The company entered i

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Odyssey Health’s 8K filing here.

Odyssey Health Company Profile

(Get Free Report)

Odyssey Health, Inc, a medical company, focuses on the development and commercialization of medical products. It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and ONP -001 and ONP -002 neurosteroid drug compounds to treat concussions and rare brain disorders.

Read More